Newstral
Article
The Hindu on 2021-01-30 22:22
Can SARS-CoV-2 mutations undercut the efficacy of vaccines?
Related news
- COVID-19 mutations undercut optimism even as more vaccines nearThe Japan Times
- Coronavirus | Mutations will not make vaccines ineffective: Principal Scientific AdvisorThe Hindu
- COVID-19 mutations undercut optimism even as more vaccines get nearStar Telegram
- New variant of SARS-CoV-2 more transmissible and affecting younger population: Health MinistryThe Hindu
- Is low efficacy of its vaccines behind China's Covid surge?The Times of India
- 10% of CSIR staff exposed to SARS-CoV-2 coronavirus, survey findsThe Hindu
- Coronavirus | 4 detected with South African variant of SARS-CoV-2 in India, one with Brazil strainThe Hindu
- Yale study finds most SARS-CoV-2 variants neutralized by mRNA vaccinesyaledailynews.com
- Explained | Why is genome sequencing crucial to track SARS-CoV-2 variants?The Hindu
- COVAX signs deal for 550 million Chinese Covid-19 vaccines amid questions over efficacyCNN
- 'Evaluate efficacy of vaccines against Omicron'The Times of India
- Different kinds of SARS-CoV-2 exist in India but none more lethal than the other: Indian Academy of Sciences PresidentThe Hindu
- India isolates BF.7 strain, to test efficacy of Covid-19 vaccinesThe Times of India
- New data show that leading covid-19 vaccines have similarly high efficacyThe Economist
- BCovid Mutations Undercut Optimism Even as More Vaccines Nearbloomberg.com
- BSARS CoV-2 and schoolsbitterrootstar.com
- The Hindu Explains | Is SARS-CoV-2 a latent virus which can recur?The Hindu
- SARS-CoV-2 not the last virus to spark a pandemic, says expertThe Hindu
- SARS-CoV-2 vaccines arrive at UABmontgomeryadvertiser.com
- Delta-plus deaths force doctors to defend efficacy of vaccinesThe Times of India